Aurobindo Pharma Ltd
Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:	524804	NSE Symbol:	AUROPHARMA	P/E :	36.31
ISIN Demat:	INE406A01037	Div & Yield %:	0.38	EPS :	32.72
Book Value:	335.47	Market Cap (Rs. Cr.):	69,615.37	Face Value :	1

Date	Headline
11-Apr-25	USFDA inspects Aurobindo Pharma's Raleigh Plant in North Carolina
09-Apr-25	CuraTeQ Biologics completes Phase 1 study of denosumab biosimilar, BP16
21-Mar-25	Aurobindo Pharma update on preferential issue by Curateq Biologics
19-Mar-25	Apitoria Pharma's Unit-V completes USFDA inspection
05-Mar-25	Auro Vaccines terminates license agreement with Hilleman Laboratories Singapore
28-Feb-25	Aurobindo Pharma acquires 80% stake in Tergene Biotech
20-Feb-25	USFDA inspects Aurobindo Pharma USA Inc.'s warehouse facility in New Jersey
06-Feb-25	Board of Aurobindo Pharma approves acquisition of 80% stake in Tergene Biotech
28-Jan-25	Apitoria Pharma's Unit 2 completes USFDA inspection
17-Jan-25	Aurobindo Pharma to table results

Company Snapshot